at Blissco


Latest at BlissCo

Investor Presentation - view here

Aug 13, 2018 — BlissCo is pleased to announce that it has earned an amendment to its ACMPR License from Health Canada to include the production of cannabis oil. Press release here

Jul 24, 2018 — BlissCo Cannabis BTV Feature


BlissCo Cannabis BTV Feature

jul 24, 2018


Canadian Stock Exchange (CSE) as BlissCo Cannabis Corp. (BLIS)

Frankfurt Stock Exchange (FRA) as BlissCo Cannabis Corp. (GQ4B:GR

Details on how US investors can buy BlissCo stock. 

BlissCo Investor Relations contact:

Press Releases and News

August 9, 2018

BlissCo Hires Experienced Clinic Leader to Drive Revenue with Patient Care and Call Center Programs

August 2, 2018

BlissCo CEO to Deliver Expert Keynote Presentation at Cannabis Business Europe 2018; Accelerates Expansion of Domestic and Global Ecosystem

July 26, 2018

BlissCo One Step Closer to Medical Cannabis Exports to Germany

July 18, 2018

BlissCo Signs Artificial Intelligence E-Commerce and Technology Agreement with Namaste to Serve Billion Dollar Cannabis E-Commerce Market

July 12, 2018

BlissCo Ecosystem Continues Expansion: Signs Base Price and Profit Sharing Supply Agreement with GreenSeal

June 29, 3018

BlissCo Reports First Quarter 2018 Financial Results: Fully Capitalized for Expansion with $3.3M to Continue Growing its Global Cannabis Ecosystem

June 25, 2018

BlissCo Receives Dried Cannabis From Ecosystem Partner Supreme for Sales License Amendment Application to Serve $200 Billion Medical Export Market

June 22, 2018

Canada Legalizes Recreational Cannabis - BlissCo Ready to Bloom

June 21, 2018

BlissCo Enters Europe with LOI for Cannabis Sales in Germany

June 20, 2018

BlissCo Enters Billion-Dollar Complementary and Alternative Medicine Market, Appoints Dr. Bryn Hyndman to Advisory Board

June 13, 2018

BlissCo Cannabis Corp Announces License Amendment Application to Produce Cannabis Oil

May 31, 2018

BlissCo Cannabis Corp Announces Listing on Frankfurt Stock Exchange

May 23, 2018

BlissCo Cannabis Corp Provides Corporate Update

MAY 7, 2018

BlissCo Cannabis Corp Receives its Cultivars at its Langley Facility

MAY 3, 2018

BlissCo Cannabis Changes Auditor to MNP LLP & Options Cancelled

APRIL 12, 2018

BlissCo Earns Occupancy Permit from Township of Langley

APRIL 2, 2018

Health Canada grants Cannabis Cultivation Licence to BlissCo

MARCH 06, 2018

BlissCo Completes Oversubscribed Raise of$5.6M and Secures Supply to Accelerate 2018 Growth

MARCH 02, 2018

CSE New Listing – BlissCo Cannabis Corp. (BLIS)

MARCH 02, 2018

BlissCo Completes Acquisition and Closes Over-Subscribed Financing

FEBRUARY 26, 2018

Supreme makes strategic investment in distribution partner and secures supply agreement with BlissCo



As Canada is primed as a global leader and first mover in the cannabis industry, BlissCo is uniquely poised in the rapidly growing multi-billion dollar market and in various international markets as cannabis regulations progress.

BlissCo, founded in 2013, is a Canadian vertically integrated cultivation, extraction and distribution focused cannabis brand that earned its Access to Cannabis for Medical Purposes Regulations (ACMPR) license to cultivate from Health Canada on March 29, 2018.

BlissCo's state-of-the-art production facility, located in Metro Vancouver, is purposefully designed as a hub for research, cultivation, processing, extraction, packaging and distribution.

Now with the ACMPR license to cultivate, BlissCo will commence its operation to harvest premium cannabis within its' urban facility in Metro Vancouver.  BlissCo also has a multi-year supply agreement in place with a Canadian Licensed Producer of characteristically sun-grown premium medicinal cannabis to purchase supply in large volumes (news release). This premium bulk cannabis will be brought to our secure and pristine facility in British Columbia for processing and then be packaged for sale and distribution to our growing patient list when BlissCo has appropriately received its license for sale. 

BlissCo was founded with the assistance of a team of advisors, including medical and naturopathic doctors, has intentionally engaged with the medical community to understand how to contribute to improved patient health with medicinal cannabis products. A large part of our strategy for growth centres on how to securely integrate and collaborate with the healthcare system.

The BlissCo team has deep domain expertise in the critical category success areas:

  • Multi-province controlled substance distribution (BC and Alberta)

  • Cultivation and product safety, consistency and security

  • Indoor cultivation, controlled environments ensuring high standards & consistent products.

  • Quality assurance, product safety, 3rd Party GMP Audits & Certifications.




Strategic partnership with the Supreme Cannabis Company

Trading on Canadian Securities Exchange (CSE:BLIS)

ACMPR License to Produce earned


Cannabis plant starting material to arrive at BlissCo's facility and growing commences. 

ACMPR Cannabis Oil Extraction License application submitted


Sign agreement to export 720 kilograms of medical cannabis to Germany


ACMPR License to Sell application submitted

Sign supply agreement with GreenSeal Cannabis

Sign e-commerce and technology service agreement with Namaste Technologies (TSXV: N) 


Confirmation of Readiness for Inspection received from Health Canada

Confirmation of Readiness for License from Health Canada

Close on purchasing facility for $2.4m

Earn Building Permit from Township of Langley
Commence Construction


ACMPR Licensed Submitted

Downloads and Links

BlissCo Cannabis Corp. CSE listing

BlissCo Cannabis Corp. Sedar filing information.

BlissCo logo

To learn more about investment opportunities please contact